Sanofi S.A. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other
companies in this sector in UNITED STATES :
Bristol-Myers Squibb Company
sales of $42.52 billion
of which 28%
was Prioritized Brands-Revlimid),
of which 26%
was Oncology), and
of which 50%
During the year ended December of 2020, sales at
Sanofi S.A. were $42.87 billion.
a very small
increase of 1.9%
versus 2019, when the company's sales were $42.06 billion.
This was the fourth straight year of sales growth at Sanofi S.A..
Sales of Vaccines saw an increase
that was more than double the company's growth rate: sales were up
7.0% in 2020, from
$6.41 billion to $6.85 billion.
Sanofi S.A. also saw significant increases in sales in
Pharmaceuticals (up 2.5% to $29.45 billion)
Not all segments of Sanofi S.A. experienced an increase in sales in 2020:
sales of Consumer Healthcare fell 3.8% to $5.04 billion.